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Abstract Systemic lupus erythematosus (SLE) is an autoim-
mune disease in which the immune system mistakenly attacks
multiple organs and tissues of the body. To elucidate the in-
volvement of blood cells in the pathogenesis of SLE, we used
transmission electron microscopy to study ultrastructure of
monocytes isolated from the blood of SLE patients. We found
that in the SLE patients, a substantial fraction of monocytes
had abnormal morphology that corresponded to the structural
signs of either necrosis or apoptosis. The number of altered
monocytes in the SLE patients was significantly higher than in
healthy subjects and related directly with the level of anti-
dsDNA autoantibodies in the blood. Our results suggest that
monocytes are involved in the pathogenesis of SLE and un-
dergo adverse necrotic and/or apoptotic changes, likely in-
duced by autoantibodies.
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1 Introduction
Systemic lupus erythematosus (SLE) is an autoimmune dis-
ease characterized by systemic inflammation, affecting
various organs and systems, including the joints, kidney, skin
and central nervous system. Inflammation in SLE is associat-
edwith production of autoantibodies, generation of circulating
immune complexes and activation of the complement system
[1]. Monocytes play a pathogenic role in this disease as a
source of secreted immunomodulators that promote activation
of the key immunoreactive T and B cells [2]. A high level of
interferon I, which correlates directly with the disease activity
[3], can promote maturation of monocytes into dendritic cells,
whose primary function is to process and present antigens to T
cells [4]. In addition, monocytes can play a role in promoting
thrombotic complications of SLE. It is known that SLE pa-
tients are predisposed to venous or arterial thrombosis [5] and
activated monocytes that express tissue factor on their surface
can contribute to the (peo)thrombotic status [6]. Also, mono-
cytes from the blood of SLE patients have been shown to
expose high levels of the procoagulant phosphatidylserine
on the cell surface that also may enhance the prothrombotic
tendency in SLE [7].
To provide a structural basis for the monocyte alterations in
SLE, we investigated morphology of monocytes isolated from
the blood of SLE patients and healthy donors using transmis-
sion electron microscopy.
2 Material and Methods
The study was approved by the Ethical Committee of Kazan
State Medical University. SLE patients were included in the
study based on the diagnostic criteria of the American College
of Rheumatology. Citrated blood was collected by venipunc-
ture from six SLE patients and three healthy aspirin-free do-
nors and centrifuged at 200g for 10 min at room temperature.
Platelet-rich plasma (PRP) was removed and the pellet was re-
suspended in a Tyrode-EDTA buffer added in the volume
* R. I. Litvinov
litvinov@mail.med.upenn.edu
1 Kazan Federal University, 18 Kremlyovskaya St., Kazan, Russian
Federation 42008
2 Kazan Institute of Biochemistry and Biophysics, 2/31 Lobachevsky
St., Kazan, Russian Federation 420111
3 University of Pennsylvania School of Medicine, 421 Curie Blvd.,
Philadelphia, PA 19104, USA
BioNanoSci. (2017) 7:636–639
DOI 10.1007/s12668-017-0441-z
